You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nucleos(t)ide analogue

Showing 1 - 25 of 9,696
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis B Virus Infection Trial in Kaohsiung, Taichung, Taipei (Ropeginterferon alfa-2b, Entecavir)

Recruiting
  • Chronic Hepatitis B Virus Infection
  • Kaohsiung, Taiwan
  • +4 more
Aug 12, 2022

Chronic Hepatitis B Trial in Beijing (TCR-T)

Active, not recruiting
  • Chronic Hepatitis B
  • TCR-T
  • Beijing, China
    The Fifth Medical Center of PLA General Hospital
Jun 13, 2023

Chronic Hepatitis B Trial (Bepirovirsen, Placebo)

Recruiting
  • Chronic Hepatitis B
  • Herston, Queensland, Australia
  • +7 more
Jan 23, 2023

Chronic Hepatitis B, High-Risk Cancer Trial in China (Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue, Nucleos(t)ide

Active, not recruiting
  • Chronic Hepatitis B
  • High-Risk Cancer
  • Peginterferon alfa-2b Injection, Nucleos (t) ide Analogue
  • Nucleos(t)ide analogue
  • Chengdu, China
  • +8 more
Jan 4, 2023

Chronic Hepatitis B Trial in Worldwide (Bepirovirsen, Placebo)

Recruiting
  • Chronic Hepatitis B
  • Victoria, British Columbia, Canada
  • +10 more
Jan 23, 2023

Chronic Hepatitis b Trial in Auckland (AB-101, Placebo, Nucleos(t)ide Analogue)

Not yet recruiting
  • Chronic Hepatitis b
  • Auckland, New Zealand
    New Zealand Clinical Research Auckland
Jul 26, 2023

After Long-Term Antiviral Treatment for Chronic Hepatitis B

Completed
  • Chronic Hepatitis B e Antigen Positive
  • Chronic Hepatitis B e Antigen Negative
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Chronic Hepatitis B Trial (RO7565020, Placebo, Nucleos(t)ide analogue (NUC) treatment)

    Not yet recruiting
    • Chronic Hepatitis B
    • (no location specified)
    Feb 28, 2023

    Chronic Hepatitis b, NAFLD, Cirrhosis Trial in Hong Kong (Empagliflozin 10 MG, Placebo pills)

    Recruiting
    • Chronic Hepatitis b
    • +5 more
    • Empagliflozin 10 MG
    • Placebo pills
    • Hong Kong, Hong Kong, China, Hong Kong
      The University of Hong Kong/Queen Mary Hospital
    May 31, 2022

    Chronic Hepatitis B After Nucleos(t)Ide Analogue Therapy

    Completed
    • Virological Breakthrough
    • Prognosis
    • Observation for clinical and virological changes
    • Changhua, Taiwan
    • +3 more
    Mar 14, 2021

    Hepatitis B, Chronic Trial in Worldwide (GSK3228836, GSK3528869A, Control)

    Recruiting
    • Hepatitis B, Chronic
    • Edegem, Belgium
    • +47 more
    Jan 24, 2023

    Chronic Hepatitis b Trial in Belgium (Cessation of ongoing treatment)

    Not yet recruiting
    • Chronic Hepatitis b
    • Cessation of ongoing treatment
    • Aalst, Belgium
    • +17 more
    Feb 26, 2021

    Chronic Hepatitis b Trial in Taiwan (Nuc Discontinuation, Entecavir or Tenofovir)

    Active, not recruiting
    • Chronic Hepatitis b
    • Nuc Discontinuation
    • Entecavir or Tenofovir
    • Chiayi City, Taiwan
    • +5 more
    Mar 30, 2023

    Liver Fibrosis Trial (PEG-Interferon Alfa, Tenofovir Disoproxil Fumarate, Tenofovir Disoproxil Fumarate)

    Not yet recruiting
    • Liver Fibrosis
    • PEG-Interferon Alfa, Tenofovir Disoproxil Fumarate
    • Tenofovir Disoproxil Fumarate
    • (no location specified)
    Nov 17, 2020

    Chronic Hepatitis B Trial in Guangzhou (NrtIs, HH-003, HH-003+NrtIs)

    Active, not recruiting
    • Chronic Hepatitis B
    • Guangzhou, Guangdong, China
      Nanfang Hospital, Southern Medical University
    Apr 20, 2023

    Chronic Hepatitis b, Hepatitis B Reactivation Trial in Taiwan (Vemlidy)

    Recruiting
    • Chronic Hepatitis b
    • Hepatitis B Reactivation
    • Chiayi City, Taiwan
    • +6 more
    Aug 4, 2021

    Chronic Hepatitis B Trial in Hong Kong, Auckland (VRON-0200-AdC6, VRON-0200-AdC7)

    Recruiting
    • Chronic Hepatitis B
    • VRON-0200-AdC6
    • VRON-0200-AdC7
    • Hong Kong, Hong Kong
    • +1 more
    Oct 6, 2023

    Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

    Terminated
    • Hepatitis B, Chronic
    • Hillsborough, New Jersey
    • +11 more
    Dec 28, 2022

    Real-world Study Optimizing Nucleotide-analogues

    Recruiting
    • Hepatitis B, Chronic
    • Hefei, Anhui, China
    • +43 more
    Jul 7, 2023

    Chronic Hepatitis B Trial run by the NIDDK (Peginterferon alfa-2a)

    Completed
    Has Results
    • Chronic Hepatitis B
    • Peginterferon alfa-2a
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 23, 2019

    Hepatitis B Trial in Worldwide (GSK3228836, Nucleos(t)ide therapy)

    Recruiting
    • Hepatitis B
    • Boston, Massachusetts
    • +3 more
    Aug 24, 2022

    Thymidine Kinase 2 Deficiency Trial (MT1621)

    Withdrawn
    • Thymidine Kinase 2 Deficiency
    • (no location specified)
    Aug 16, 2022

    Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)

    Active, not recruiting
    • Hepatitis B, Chronic
    • Edegem, Belgium
    • +12 more
    Jan 17, 2023

    Chronic HBV Infection Trial in China (Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs), HH-003 and NrtIs, HH-003,

    Recruiting
    • Chronic HBV Infection
    • Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs)
    • +2 more
    • Beijing, Beijing, China
    • +7 more
    Feb 23, 2023

    Chronic Hepatitis B Trial in Singapore (stopping nucleos(t)ide therapy, Continue nucleos(t)ide analogue)

    Unknown status
    • Chronic Hepatitis B
    • stopping nucleos(t)ide therapy
    • Continue nucleos(t)ide analogue
    • Singapore, Singapore
      National University Hospital
    Sep 24, 2019